112 related articles for article (PubMed ID: 7863466)
1. Evidence for the existence of two different ADP-binding sites on rat platelets.
Savi P; Laplace MC; Herbert JM
Thromb Res; 1994 Oct; 76(2):157-69. PubMed ID: 7863466
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
3. Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel.
Savi P; Bornia J; Salel V; Delfaud M; Herbert JM
Br J Haematol; 1997 Sep; 98(4):880-6. PubMed ID: 9326183
[TBL] [Abstract][Full Text] [Related]
4. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets.
Savi P; Artçanuthurry V; Bornia J; Grelac F; Maclouf J; Levy-Toledano S; Herbert JM
Br J Haematol; 1997 Apr; 97(1):185-91. PubMed ID: 9136964
[TBL] [Abstract][Full Text] [Related]
5. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.
Gachet C; Cattaneo M; Ohlmann P; Hechler B; Lecchi A; Chevalier J; Cassel D; Mannucci PM; Cazenave JP
Br J Haematol; 1995 Oct; 91(2):434-44. PubMed ID: 8547091
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
7. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation.
Humbert M; Nurden P; Bihour C; Pasquet JM; Winckler J; Heilmann E; Savi P; Herbert JM; Kunicki TJ; Nurden AT
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1532-43. PubMed ID: 8977459
[TBL] [Abstract][Full Text] [Related]
9. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
10. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
[TBL] [Abstract][Full Text] [Related]
11. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
12. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
13. cAMP is not an important messenger for ADP-induced platelet aggregation.
Savi P; Pflieger AM; Herbert JM
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):249-52. PubMed ID: 8735831
[TBL] [Abstract][Full Text] [Related]
14. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
15. Identification and biological activity of the active metabolite of clopidogrel.
Savi P; Pereillo JM; Uzabiaga MF; Combalbert J; Picard C; Maffrand JP; Pascal M; Herbert JM
Thromb Haemost; 2000 Nov; 84(5):891-6. PubMed ID: 11127873
[TBL] [Abstract][Full Text] [Related]
16. ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel.
Gachet C; Savi P; Ohlmann P; Maffrand JP; Jakobs KH; Cazenave JP
Thromb Haemost; 1992 Jul; 68(1):79-83. PubMed ID: 1514178
[TBL] [Abstract][Full Text] [Related]
17. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
18. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
20. Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor.
Kuijpers MJ; Megens RT; Nikookhesal E; Feijge MA; De Mey JG; oude Egbrink MG; van Giezen JJ; Heemskerk JW
Thromb Haemost; 2011 Dec; 106(6):1179-88. PubMed ID: 22071958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
